Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma
- PMID: 16574030
- DOI: 10.1185/030079906X89711
Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma
Abstract
Objective: To determine resource utilization in controller naïve children diagnosed with asthma receiving initial therapy with fluticasone propionate (FP) and salmeterol (SAL) in a single inhaler (FSC), FP alone, montelukast (MON), inhaled corticosteroid (ICS) + SAL from separate inhalers, or ICS + MON.
Research design and methods: A retrospective, observational, 18-month (6-month pre-index and 12-month follow-up) database study using medical and pharmacy claims from a 5 million member managed care organization. Multivariate modeling was used to evaluate post-index resource utilization and asthma-related costs. Refill rates during the 12-month follow-up period were compared across cohorts.
Results: The study included controller-naïve children (n = 9192) aged 4-17 years with an asthma diagnosis. Children treated with FSC were significantly less likely to receive additional prescriptions for short-acting beta-agonists compared with all other cohorts (p <or= 0.007) and oral corticosteroids compared with the MON, ICS + SAL, and ICS + MON cohorts (p <or= 0.009). Children receiving FSC were also significantly less likely to add another controller therapy compared with children started on FP alone, MON, or ICS + SAL (p <or= 0.001) and to receive care in an emergency department or hospital compared with children receiving ICS + MON (p < 0.001). The number of prescriptions for FSC in the 12-month post-index period was greater (p < 0.05) than the number of ICS claims in the FP, ICS + SAL, and ICS + MON cohorts. Compared with FSC, the adjusted total asthma-related post-index costs were greater (p <or= 0.008) in the MON and ICS + MON cohorts. Although adherence was greater with MON compared with FSC, MON was associated with less favorable clinical outcomes and greater resource utilization and costs.
Conclusion: FSC in children is associated with improved clinical outcomes and decreased resource utilization compared with other controller regimens.
Similar articles
-
Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.Clin Ther. 2008 Mar;30(3):560-71. doi: 10.1016/j.clinthera.2008.03.011. Clin Ther. 2008. PMID: 18405796
-
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.J Allergy Clin Immunol. 2004 Feb;113(2):245-51. doi: 10.1016/j.jaci.2003.10.011. J Allergy Clin Immunol. 2004. PMID: 14767437
-
Adherence to asthma controller medication regimens.Respir Med. 2005 Oct;99(10):1263-7. doi: 10.1016/j.rmed.2005.03.002. Epub 2005 Apr 12. Respir Med. 2005. PMID: 16140227
-
Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.J Allergy Clin Immunol. 2001 Feb;107(2):398-416. doi: 10.1067/mai.2001.112939. J Allergy Clin Immunol. 2001. PMID: 11174215 Review.
-
[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].Med Klin (Munich). 2008 May 15;103(5):299-310. doi: 10.1007/s00063-008-1050-y. Med Klin (Munich). 2008. PMID: 18484216 Review. German.
Cited by
-
Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol.BMJ Open Respir Res. 2023 Aug;10(1):e001706. doi: 10.1136/bmjresp-2023-001706. BMJ Open Respir Res. 2023. PMID: 37620110 Free PMC article.
-
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies.Respir Res. 2014 Jul 19;15(1):83. doi: 10.1186/1465-9921-15-83. Respir Res. 2014. PMID: 25038591 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical